Clinical Trial Update: Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF [NA]

View source ↗

Summary

Clinical trial update on weight management using GLP-1 receptor agonists to influence ablation outcomes in overweight/obese patients with type 2 diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Type 2 Diabetes Mellitus (T2DM), Atrial Fibrillation (AF) | NA | Status: COMPLETED